Status:
COMPLETED
Health Consequences of the Burden of Atrial Fibrillation
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Swiss National Science Foundation
Clinical Trial Unit, University Hospital Basel, Switzerland
Conditions:
Atrial Fibrillation
Burden
Eligibility:
All Genders
45+ years
Brief Summary
The Swiss-AF-BURDEN study will be embedded in the follow-up visits of the Swiss-AF cohort study. The research question of the current atrial fibrillation burden will be answered by using 7-day Holter-...
Eligibility Criteria
Inclusion
- Swiss-AF study patient
- Paroxysmal or persistent AF
Exclusion
- Permanent AF
- Swiss-AF patients not willing or able to undergo 7-day Holter monitoring
- Specifically for cMRI: Pregnant women or women of child-bearing age without a prior negative pregnancy test
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2024
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT05389228
Start Date
August 1 2018
End Date
January 7 2024
Last Update
March 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland